{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:41:33Z","timestamp":1792550493621,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01NS106879"],"award-info":[{"award-number":["1R01NS106879"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["14BGIA20380826"],"award-info":[{"award-number":["14BGIA20380826"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.mehy.2019.109309","type":"journal-article","created":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T01:53:41Z","timestamp":1562982821000},"page":"109309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Peptidase neurolysin is an endogenous cerebroprotective mechanism in acute neurodegenerative disorders"],"prefix":"10.1016","volume":"131","author":[{"given":"Vardan T.","family":"Karamyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2019.109309_b0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18081788","article-title":"The role of neurogenic inflammation in blood-brain barrier disruption and development of cerebral oedema following acute central nervous system (CNS) injury","volume":"18","author":"Sorby-Adams","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.mehy.2019.109309_b0010","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/nn.2953","article-title":"Stroke research at a crossroad: asking the brain for directions","volume":"14","author":"Iadecola","year":"2011","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.mehy.2019.109309_b0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/jnc.13362","article-title":"Endogenous recovery after brain damage: molecular mechanisms that balance neuronal life\/death fate","volume":"136","author":"Tovar-y-Romo","year":"2016","journal-title":"J Neurochem"},{"key":"10.1016\/j.mehy.2019.109309_b0020","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.bpa.2010.10.001","article-title":"Acute pathophysiological processes after ischaemic and traumatic brain injury","volume":"24","author":"Kunz","year":"2010","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"10.1016\/j.mehy.2019.109309_b0025","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/01.WCB.0000111614.19196.04","article-title":"Pathophysiology of cerebral ischemia and brain trauma: similarities and differences","volume":"24","author":"Bramlett","year":"2004","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.mehy.2019.109309_b0030","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S1474-4422(03)00482-4","article-title":"Neuropeptides: opportunities for drug discovery","volume":"2","author":"Hokfelt","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.mehy.2019.109309_b0035","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.regpep.2007.03.006","article-title":"Enzymatic pathways of the brain renin-angiotensin system: unsolved problems and continuing challenges","volume":"143","author":"Karamyan","year":"2007","journal-title":"Regul Pept"},{"key":"10.1016\/j.mehy.2019.109309_b0040","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10741-007-9078-2","article-title":"The significance of brain aminopeptidases in the regulation of the actions of angiotensin peptides in the brain","volume":"13","author":"Speth","year":"2008","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.mehy.2019.109309_b0045","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1210\/er.2001-0032","article-title":"Soluble metalloendopeptidases and neuroendocrine signaling","volume":"23","author":"Shrimpton","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1016\/j.mehy.2019.109309_b0050","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jocn.2017.11.018","article-title":"Peptidase neurolysin: Its function related to the brain renin-angiotensin system and pathophysiology of stroke. Letter to the Editor","volume":"48","author":"Rashid","year":"2018","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.mehy.2019.109309_b0055","doi-asserted-by":"crossref","first-page":"6106","DOI":"10.1007\/s12035-015-9520-8","article-title":"Role of matrix metalloproteinases in the pathogenesis of traumatic brain injury","volume":"53","author":"Abdul-Muneer","year":"2016","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.mehy.2019.109309_b0060","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejphar.2008.05.035","article-title":"Characterization of the brain-specific non-AT(1), non-AT(2) angiotensin binding site in the mouse","volume":"590","author":"Karamyan","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.mehy.2019.109309_b0065","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.brainres.2007.01.051","article-title":"Identification of a novel non-AT1, non-AT2 angiotensin binding site in the rat brain","volume":"1143","author":"Karamyan","year":"2007","journal-title":"Brain Res"},{"key":"10.1016\/j.mehy.2019.109309_b0070","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.lfs.2008.07.003","article-title":"Human brain contains a novel non-AT1, non-AT2 binding site for active angiotensin peptides","volume":"83","author":"Karamyan","year":"2008","journal-title":"Life Sci"},{"key":"10.1016\/j.mehy.2019.109309_b0075","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1159\/000140635","article-title":"Distribution of the non-AT1, non-AT2 angiotensin-binding site in the rat brain: preliminary characterization","volume":"88","author":"Karamyan","year":"2008","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.mehy.2019.109309_b0080","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1074\/jbc.M111.273052","article-title":"Identification of membrane-bound variant of metalloendopeptidase neurolysin (EC 3.4.24.16) as the non-angiotensin type 1 (Non-AT1), Non-AT2 angiotensin binding site","volume":"287","author":"Wangler","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2019.109309_b0085","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1124\/jpet.110.171439","article-title":"Association of the novel non-AT1, non-AT2 angiotensin binding site with neuronal cell death","volume":"335","author":"Rashid","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.mehy.2019.109309_b0090","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/jnc.12513","article-title":"Functional upregulation of endopeptidase neurolysin during post-acute and early recovery phases of experimental stroke in mouse brain","volume":"129","author":"Rashid","year":"2014","journal-title":"J Neurochem"},{"key":"10.1016\/j.mehy.2019.109309_b0095","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1111\/j.1471-4159.1992.tb11021.x","article-title":"Endopeptidase 24\u201316 in murines: tissue distribution, cerebral regionalization, and ontogeny","volume":"59","author":"Dauch","year":"1992","journal-title":"J Neurochem"},{"key":"10.1016\/j.mehy.2019.109309_b0100","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0301-0082(95)00024-P","article-title":"Apoptosis in the developing CNS","volume":"47","author":"Naruse","year":"1995","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.mehy.2019.109309_b0105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0304-3940(00)01368-9","article-title":"Analysis of neurogenesis and programmed cell death reveals a self-renewing capacity in the adult rat brain","volume":"291","author":"Biebl","year":"2000","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.mehy.2019.109309_b0110","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0166-2236(00)01562-9","article-title":"Recovery recapitulates ontogeny","volume":"23","author":"Cramer","year":"2000","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.mehy.2019.109309_b0115","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1523\/JNEUROSCI.16-16-05049.1996","article-title":"Distinct properties of neuronal and astrocytic endopeptidase 3.4.24.16: a study on differentiation, subcellular distribution, and secretion processes","volume":"16","author":"Vincent","year":"1996","journal-title":"J Neurosci"},{"key":"10.1016\/j.mehy.2019.109309_b0120","doi-asserted-by":"crossref","first-page":"H1942","DOI":"10.1152\/ajpheart.00948.2002","article-title":"Metalloendopeptidases EC 3.4.24.15\/16 regulate bradykinin activity in the cerebral microvasculature","volume":"284","author":"Norman","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.mehy.2019.109309_b0125","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1007\/s11064-018-2624-6","article-title":"Neurolysin: from initial detection to latest advances","volume":"43","author":"Checler","year":"2018","journal-title":"Neurochem Res"},{"key":"10.1016\/j.mehy.2019.109309_b0130","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/sj.bjp.0705415","article-title":"Bradykinin B2 receptor antagonism: a new direction for acute stroke therapy?","volume":"139","author":"Sobey","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.mehy.2019.109309_b0135","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pneurobio.2012.11.004","article-title":"Ischemic stroke and traumatic brain injury: the role of the kallikrein-kinin system","volume":"101\u2013102","author":"Albert-Weissenberger","year":"2013","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.mehy.2019.109309_b0140","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/cercor\/bhh008","article-title":"Neurotensin enhances endogenous extracellular glutamate levels in primary cultures of rat cortical neurons: involvement of neurotensin receptor in NMDA induced excitotoxicity","volume":"14","author":"Antonelli","year":"2004","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.mehy.2019.109309_b0145","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1093\/cercor\/bhm217","article-title":"Neurotensin receptor involvement in the rise of extracellular glutamate levels and apoptotic nerve cell death in primary cortical cultures after oxygen and glucose deprivation","volume":"18","author":"Antonelli","year":"2008","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.mehy.2019.109309_b0150","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.2174\/138955709789957495","article-title":"Emerging evidence for neurotensin receptor 1 antagonists as novel pharmaceutics in neurodegenerative disorders","volume":"9","author":"Ferraro","year":"2009","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.mehy.2019.109309_b0155","doi-asserted-by":"crossref","first-page":"17656","DOI":"10.1038\/s41598-018-36330-2","article-title":"The potential of substance P to initiate and perpetuate cortical spreading depression (CSD) in rat in vivo","volume":"8","author":"Richter","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.mehy.2019.109309_b0160","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/bph.13155","article-title":"Inflammation in acute CNS injury: a focus on the role of substance P","volume":"173","author":"Corrigan","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.mehy.2019.109309_b0165","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1113\/expphysiol.2011.058578","article-title":"Cerebroprotection by angiotensin-(1\u20137) in endothelin-1-induced ischaemic stroke","volume":"96","author":"Mecca","year":"2011","journal-title":"Exp Physiol"},{"key":"10.1016\/j.mehy.2019.109309_b0170","doi-asserted-by":"crossref","DOI":"10.1089\/neu.2019.6376","article-title":"Subcutaneous administration of angiotensin-(1\u20137) improves recovery after traumatic brain injury in mice","author":"Janatpour","year":"2019","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.mehy.2019.109309_b0175","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1161\/01.STR.0000115162.16321.AA","article-title":"Hypertension, angiotensin, and stroke: beyond blood pressure","volume":"35","author":"Iadecola","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.mehy.2019.109309_b0180","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/ajh\/hpu197","article-title":"Neuroprotective effects of angiotensin receptor blockers","volume":"28","author":"Villapol","year":"2015","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.mehy.2019.109309_b0185","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1385\/NMM:7:1-2:037","article-title":"Cannabinoid receptors and their role in neuroprotection","volume":"7","author":"van der Stelt","year":"2005","journal-title":"Neuromol Med"},{"key":"10.1016\/j.mehy.2019.109309_b0190","doi-asserted-by":"crossref","first-page":"414","DOI":"10.2174\/1871527316666170320150659","article-title":"Utilizing delta opioid receptors and peptides for cytoprotection: implications in stroke and other neurological disorders","volume":"16","author":"Crowley","year":"2017","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.mehy.2019.109309_b0195","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.drudis.2018.02.011","article-title":"The neuroprotective role of the brain opioid system in stroke injury","volume":"23","author":"Vaidya","year":"2018","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.mehy.2019.109309_b0200","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1096\/fj.11-201822","article-title":"A novel stroke therapy of pharmacologically induced hypothermia after focal cerebral ischemia in mice","volume":"26","author":"Choi","year":"2012","journal-title":"Faseb J"},{"key":"10.1016\/j.mehy.2019.109309_b0205","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.neuropharm.2007.01.020","article-title":"Substance P provides neuroprotection in cerebellar granule cells through Akt and MAPK\/Erk activation: evidence for the involvement of the delayed rectifier potassium current","volume":"52","author":"Amadoro","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.mehy.2019.109309_b0210","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17060991","article-title":"Serum levels of substance P and mortality in patients with a severe acute ischemic stroke","volume":"17","author":"Lorente","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.mehy.2019.109309_b0215","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1161\/ATVBAHA.116.307847","article-title":"Circulating proneurotensin concentrations and cardiovascular disease events in the community: the framingham heart study","volume":"36","author":"Januzzi","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.mehy.2019.109309_b0220","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1089\/neu.2012.2774","article-title":"Bradykinin in blood and cerebrospinal fluid after acute cerebral lesions: correlations with cerebral edema and intracranial pressure","volume":"30","author":"Kunz","year":"2013","journal-title":"J Neurotrauma"},{"issue":"Supplement","key":"10.1016\/j.mehy.2019.109309_b0225","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/978-3-211-98811-4_39","article-title":"Substance P immunoreactivity increases following human traumatic brain injury","volume":"106","author":"Zacest","year":"2010","journal-title":"Acta Neurochirurgica"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987719305948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987719305948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:16:34Z","timestamp":1759691794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987719305948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":45,"alternative-id":["S0306987719305948"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2019.109309","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peptidase neurolysin is an endogenous cerebroprotective mechanism in acute neurodegenerative disorders","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2019.109309","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109309"}}